*m Mean sexual activity scores rose from 2.43 points at baseline to 4.28 points at day 105 for men receiving oral testosterone undecanoate, a 1.85-point improvement during the trial.
“Just to put this in perspective, when we look at the TRAVERSE trial, that change [in sexual activity score] was about 1 [point],” Khera said. “This is significantly higher.”
Oral testosterone undecanoate significantly improved serum testosterone levels and sexual activity among men with hypogonadism, according to a subanalysis of a phase 3 trial presented at the Androgen Society annual meeting. The inTUne phase 3 trial was conducted to assess the safety and efficacy...